SHIONOGI & CO LTD - Dusseldorf Stock Exchang (SH0 DU) stock market data APIs
€14.4064
0(0%)
as of July 4, 2025
Try our APIs with
free plan!
SHIONOGI & CO LTD - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for SH0.DU.
Prev. Close
14.4064
Open
14.4064
High
14.4064
Low
14.4064
52 wk Range
11.3626-15.2
Market Cap
18 118 M
Dividends (Yield)
1.0834
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SHIONOGI & CO LTD - Dusseldorf Stock Exchang data using free add-ons & libraries
Get SHIONOGI & CO LTD - Dusseldorf Stock Exchang Fundamental Data
SHIONOGI & CO LTD - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get SHIONOGI & CO LTD - Dusseldorf Stock Exchang Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get SHIONOGI & CO LTD - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SHIONOGI & CO LTD - Dusseldorf Stock Exchang News
New
Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan
BAAR, Switzerland & OSAKA, Japan & TOKYO, July 03, 2025--(BUSINESS WIRE)--Stallergenes Greer, Shionogi & Co., Ltd. ("Shionogi") and CEOLIA Pharma Co. Ltd ("CEOLIA") today announced the transition of p...
AN Venture Partners Announces Final Close of $200M Fund I
One of the largest Japan focused biotech funds to date SAN FRANCISCO & TOKYO, July 02, 2025--(BUSINESS WIRE)--AN Venture Partners (ANV), a global biotech venture capital firm, today announced the fin...
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
BioVersys Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, July 02, 2025 (GLOBE NEWSWIRE) -- The Global Research Collaboration is a research and exclusive license option agreement wit...
Shionogi & Co. (SGIOY) Upgraded to Buy: What Does It Mean for the Stock?
Investors might want to bet on Shionogi & Co., Ltd. Unsponsored ADR (SGIOY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings esti...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
